Reuters logo
BRIEF-Peregrine Pharmaceuticals reports Q1 loss per share $0.06
2017年9月11日 / 晚上9点14分 / 14 天前

BRIEF-Peregrine Pharmaceuticals reports Q1 loss per share $0.06

Sept 11 (Reuters) - Peregrine Pharmaceuticals Inc

* Peregrine Pharmaceuticals reports financial results for first quarter of fiscal year 2018 and recent developments

* Q1 loss per share $0.06

* Sees Q2 2018 manufacturing revenue $50 million to $55 million

* Peregrine Pharmaceuticals Inc - ‍Most of backlog is expected to be recognized during remainder of FY 2018​

* Peregrine Pharmaceuticals Inc - “ Avid bioservices current manufacturing revenue backlog is $33 million”

* Istar Inc - Company is providing manufacturing revenue guidance for full FY 2018 of $50 million - $55 million

* FY2018 revenue view $56.0 million -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below